Free Trial

Schonfeld Strategic Advisors LLC Has $7.88 Million Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Schonfeld Strategic Advisors LLC increased its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 468.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 122,767 shares of the company's stock after buying an additional 101,164 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in Ryan Specialty were worth $7,877,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its position in Ryan Specialty by 5.7% during the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock worth $633,933,000 after acquiring an additional 529,631 shares during the period. Bessemer Group Inc. lifted its holdings in shares of Ryan Specialty by 2.5% during the 4th quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock worth $210,651,000 after acquiring an additional 79,976 shares during the period. Blair William & Co. IL boosted its position in Ryan Specialty by 0.6% in the fourth quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock valued at $177,464,000 after buying an additional 16,540 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after acquiring an additional 981,505 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Ryan Specialty by 2.7% during the fourth quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock worth $115,468,000 after purchasing an additional 46,960 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.

Insider Buying and Selling at Ryan Specialty

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 11.10% of the stock is owned by corporate insiders.

Ryan Specialty Price Performance

Shares of Ryan Specialty stock traded up $2.08 during trading on Wednesday, reaching $71.31. The company's stock had a trading volume of 282,775 shares, compared to its average volume of 967,440. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The business has a 50 day moving average price of $70.13 and a 200-day moving average price of $68.71. Ryan Specialty Holdings, Inc. has a 12-month low of $51.69 and a 12-month high of $77.16. The company has a market capitalization of $18.68 billion, a P/E ratio of 102.92, a price-to-earnings-growth ratio of 1.19 and a beta of 0.68.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, hitting analysts' consensus estimates of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. During the same quarter in the prior year, the company posted $0.35 EPS. The business's revenue for the quarter was up 25.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend is Tuesday, May 13th. Ryan Specialty's payout ratio is currently 141.18%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on RYAN shares. TD Cowen began coverage on Ryan Specialty in a research note on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target for the company. Wells Fargo & Company lowered their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. UBS Group raised their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Barclays reduced their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. Finally, Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Ryan Specialty presently has an average rating of "Moderate Buy" and a consensus price target of $75.67.

Read Our Latest Stock Report on RYAN

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Further Reading

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines